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Physical activity ameliorates the association between sedentary behavior and 
cardiometabolic risk among inpatients with Schizophrenia: A comparison versus 
controls using accelerometry 
 
Abstract 
Objective: A lack of clarity exists regarding the relationship between objectively 
measured physical activity (PA) and sedentary behavior (SB) and cardiometabolic 
outcomes in people with schizophrenia. We conducted a large study investigating the 
independent relationships of PA and SB among inpatients with schizophrenia versus 
healthy controls (HCs).  
Methods: A cross sectional study including 199 inpatients with schizophrenia (mean 
age 44.0 years, mean illness duration 23.8 years) versus 60 age/ sex/ body mass index 
matched HCs. Participants wore accelerometers for 7 days to capture SB and daily 
steps. Cardiometbaolic outcomes included blood pressure, fasting blood glucose 
(FBG), triglycerides, high-density lipoprotein cholesterol (HDL-C) and waist 
circumference (WC). Multivariate regression analyses adjusting for multiple 
confounders were undertaken. 
Results: Compared to HCs, patients engaged in more sedentary behavior and less 
daily steps versus HCs (p<0.001). Patients with higher levels of SB (n=89) had 
increased fasting glucose compared to patients with low levels of SB (105.2 v 96.3 
mg/dl, p<0.05).  In the multivariate analysis, sedentary behavior was associated with 
higher FBG (β.146, p=.041) but this was ameliorated when daily steps were inserted 
in to the model (β.141, p=.059). In the final model, higher daily steps were associated 
with more favorable HDL-C (β=-.226, p=.004), independent of SB and other 
confounders. 
Conclusions: Our data suggest that higher whilst sedentary behaviour is related to 
worse fasting glucose, this relationship is attenuated when PA is taken into account.  
Physical activity is also associated with favourable HDL-C. Interventions targeting 
replacing sedentary behavior with PA may improve metabolic risk. 
 
Key words: physical activity, inactivity, MetS, metabolic syndromes, psychosis 
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Physical activity ameliorates the association between sedentary behavior and 
cardiometabolic risk among inpatients with Schizophrenia: A comparison versus 
controls using accelerometry 
 
1. Introduction 
There is now irrefutable evidence that people with schizophrenia have a greatly 
reduced life expectancy [1]. The greatest contributors to this premature mortality are 
physical health conditions and in particular cardiometabolic and cardiovascular 
disease [2]. People with schizophrenia have greatly increased levels of metabolic 
syndrome [3] whilst approximately 12% have type 2 diabetes [4, 5]. The heightened 
cardiometabolic risk is evident in the earlier stages of illness, including those who are 
antipsychotic naïve [4] and is elevated in youth who have recently been exposed to 
antipsychotic medication [6]. Whilst genetic factors may also contribute to the 
heightened cardiometabolic risk, there is an increasing realization that lifestyle factors 
may have a key role in cardiometabolic risk in people with schizophrenia [7]. 
In the general population, there is an established evidence base that physical 
activity offers a protective effect against the development of an adverse metabolic 
profile [8, 9]. Of concern, a recent meta-analysis established that people with 
schizophrenia engaged in low levels of physical activity and approximately half do 
not meet the recommended weekly guidelines [10]. To date, a small number of studies 
[11, 12] have suggested that lower levels of activity are associated with a worse 
metabolic profile. Whilst helpful, almost all of these studies have relied on small 
sample sizes (n<75) and relied upon self-report physical activity measures which are 
known to have questionable accuracy and psychometric properties [13]. 
There is also a growing evidence base in the general population that sedentary 
behavior, independent from physical activity, is associated with an increased risk of 
diabetes, cardiovascular disease and mortality[14]. Sedentary behavior is defined as 
any waking activity characterized by an energy expenditure ≤ 1.5 metabolic equivalents 
including tasks such as sitting or reclining posture [15]. A recent meta-analysis 
demonstrated that people with schizophrenia spend approximately 12.5 hours a day 
being sedentary which is among the highest in any population in the world [16]. Two 
studies have suggested that self-report sitting behavior is associated with adverse 
metabolic profile [17, 18]. Whilst helpful in furthering our understanding the potential 
deleterious relationship of sedentary behavior on people with schizophrenia, the 
reliance upon self-report sedentary behavior introduces a bias, and the question of 
whether physical activity and sedentary behavior have independent influences on 
metabolic profiles remains unanswered. 
Given the aforementioned, the current study had the following aims: 1) Compare 
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objectively measured sedentary behavior and physical activity among inpatients with 
schizophrenia versus controls. 2) Investigate the potential independent relationships 
between sedentary behavior and physical activity with cardiometabolic outcomes 
among inpatients with schizophrenia.  
 
2. Methods 
The current study adopted a cross sectional design and took place in Taiwan [19]. 
 
2.1 Participants 
Participants who were residing across six long stay psychiatric wards at Jianan 
Mental Hospital, were invited to take part in the current study. Specific inclusion 
criteria were 1) Diagnosis of schizophrenia (according to DSM IV [20] made by an 
independent psychiatrist), 2) Individuals who were stable and on the same 
antipsychotic medicine regime for at least three months. Exclusion criteria included 
patients who were unable to communicate, immobile, or had any major neurological 
disorder (e.g. stroke). 
A healthy control group was recruited from the staff of two hospitals and 
universities. The control group was matched with patients according to age, sex and 
body mass index (BMI). Specific inclusion criteria were a) No present or past history 
of any mental illness, b) not taking any psychotropic medication. A total of 60 
participants were selected to ensure comparable gender balance, age and BMI ranges 
to the schizophrenia group. 
The study was approved by the Institutional Review Board of Jianan Mental 
Hospital. All participants provided informed written consent. 
 
2.2 Measures 
2.2.1 Outcome variable: Cardiometabolic risk factors 
The parameters of cardiometabolic risk factors collected included waist 
circumference (WC), systolic/diastolic blood pressure (SBP/DBP), serum triglyceride 
(TG), high-density lipoprotein cholesterol (HDL-C), and fasting glucose (FBG). WC, 
SBP, and DBP were measured by the hospital nurses. Data on TG, HDL-C, and FBG 
were obtained through venous blood samples, which were taken in the morning before 
breakfast and examined in the hospital. 
 
2.2.2 Independent variable: Sedentary behavior and steps per day 
Sedentary behaviour and steps per day were captured using the ActiGraph 
(wActiSleep, Pensacola, FL, USA), a tri-axial accelerometer. The ActiGraph has been 
validated previously among people with schizophrenia [21-24]. Accelerometers are 
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the optimal free living measure in people with schizophrenia, since self-report 
measures such as the IPAQ [25] lack accuracy [13]. Research assistants provided the 
standardized instructions for wearing the accelerometers. Specifically, participants 
were told to wear the accelerometer on the wrist of the non-dominant hand for 7 
consecutive days and to remove it during bathing or water activities. The 
accelerometers were initialized, downloaded and analyzed with ActiLife software 
version 6 (ActiGraph LLC). Sedentary behaviour was defined according to the cut-off 
point outlined by Freedson [26] as activities≦100 counts per minute (cpm), 
representing a threshold corresponding with sitting, reclining, or lying down. The 
steps per day were also calculated by the software and were used to present physical 
activity among participants. Sedentary time and steps were categorized into two levels: 
‘Low and High’ in a binary split about the mean in order to demonstrate differences in 
key variables between these groups among inpatients with schizophrenia. 
 
2.2.3 Covariates 
Details of participants sociodemographic information was collected including 
data on age (≦40 or >40), sex, smoking habits, alcohol consumption, and education. 
Participants smoking and alcohol status were subsequently categorized based on 
self-report as ‘Yes (current/former smoker or drinker)’ and ‘No’ (never). 
Positive and negative syndrome scale (PANSS). All patients completed the 
PANSS[27], a tool specifically developed to assess the severity of symptoms and 
measure general psychopathology among patients with schizophrenia [27]. The 
PANSS is a 30-item rating scale, including three subscales: Positive Symptoms (7 
items), Negative Symptoms (7 items), and General Psychopathology (16 items). For 
each item, there are seven rating points with increasing levels of psychopathology 
severity from 1 (asymptomatic) to 7 (extremely symptomatic). The PANSS score is 
the sum of ratings across items, with ranging between 7-49 for the Positive and 
Negative Scales and 16-112 for the General Psychopathology Scale. Higher scores 
demonstrate more severe symptoms. 
Medications. Information of antipsychotics medications and sleeping pills use 
was collected through the hospital records. The use of antipsychotics medications was 
converted into a daily equivalent dosage of chlorpromazine [28] and the daily 
equipotent dosage of Lorazepam were also calculated for each patient based on the 
defined daily dose (DDD) of WHO Collaborating Centre for Drug Statistics 
Methodology [29] (http://www.whocc.no/ddd/definition_and_general_considera/). 
 
2.3. Statistical analyses 
The percentages or differences between patients with schizophrenia and the 
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control group were examined using independent t-tests and Chi-square tests. 
Differences of sedentary time, steps, metabolic parameters, and clinical state profiles 
between levels of sedentary behaviors and steps in patients with schizophrenia were 
examined by independent t-tests. Two-step forced entry multivariate regression 
analyses were computed to examine the associations of sedentary levels on each 
metabolic parameter. The dependent variable was sedentary levels and variables 
entered into the model were demographic variables (age, sex, education), smoking, 
alcohol consumption, medications, and PANSS, followed by steps. All analyses were 
performed with IBM SPSS statistics 22 and a p-value less than 0.05 was considered as 
statistically significant in this study. 
 
3. Results 
Overall, from 200 participants who were approached, 199 inpatients took part in 
the current study. On average, inpatients were 44.0 years old, with a mean illness 
duration of 23.8 years and almost two thirds were male (full details summarized in 
table 1). The healthy control group was of similar age, sex and BMI, however patients 
were more likely to smoke, have a lower number of years in education, whilst no 
difference was observed in alcohol intake (table 1). 
Table 1 here 
 
3.1 Differences in sedentary behavior, daily steps and cardiometabolic risk in patients 
versus controls 
Full details are presented in figure 1. Briefly, patients engaged in significantly 
more sedentary behavior (581.1 v 336.4 minutes per day, p<0.001) and less daily 
steps (6628 v 10976, p<0.001). Moreover, patients had a higher waist circumference, 
triglyceride and fasting blood glucose but lower HDL-C (figure 1). No difference in 
systolic or diastolic blood pressure was observed. 
Figure 1 here 
 
3.2 Differences in cardiometabolic profile between patients with low and high 
sedentary behavior and daily steps 
Table 2 provides a summary of the univariate analyses comparing key variables 
between patients with high and low sedentary behavior and daily steps. Compared to 
patients with lower levels of sedentary behavior (n=110), patients with higher levels 
of sedentary behavior (n=89) had increased fasting glucose (105.2 v 96.3 mg/dl, 
p<0.05) and a longer hospital stay (11.5 v 16.1 months, p<0.05). Patients with higher 
levels of daily steps (n=106) had an increased HDL-C (mg/dl) and longer hospital 
duration versus patients with less daily steps (n=93) (table 2). 
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Table 2 here 
 
3.3 Exploring the independent relationships between sedentary behavior and daily 
steps with cardiometabolic profile in patients 
Table 3 reports the multivariate associations between sedentary behavior and each 
cardiometabolic outcome. Only higher levels of sedentary behavior were associated 
with increased fasting blood glucose after the adjustment of multiple other risk factors 
(β=.146, p=0.42). After adjusting for daily steps in the final model (table 4), the 
relationship between sedentary behavior and fasting glucose moved beyond the 
threshold of significance (p=0.59). In the final adjusted model, lower daily steps was 
significantly associated with lower HDL-C independent of sedentary behavior and 
multiple other confounders (β-.226, p=.004). 
Table 3 and 4 here 
 
In a sensitivity analysis, inpatients were categorized into three groups according 
to antipsychotic medication: first generation (n=47), second generation (n=115) and 
First+Second generation combined (n=37). We performed ANOVA tests and found no 
significant difference between drug types and Waist, SBP, DBP, TG, or FBG. The 
only significant difference was found between drug types and HDL-C (p=.019) (First 
generation: HDL-C = 42.83(mean), Second: 49.08, First+Second: 45.54; 
First>Second, p=.024). Finally, we conducted the regression models for HDL-C and 
FBG (because steps and sedentary time were only significantly related to these two 
variables) replacing the Chlopromazine doses with the dummy variable (drug types). 
Similar results were found for the association of step/sedentary with HDL-C or FBG 
as to the original model using chlorpromazine equivalents (results available from 
corresponding author on request).   
 
4. Discussion 
To our knowledge, the current study is the first to explore the independent 
relationships between objectively measured sedentary behavior and daily steps and 
cardiometabolic risk factors among inpatients  with schizophrenia and controls. The 
study has produced several novel findings. First, our data suggest that among 
inpatients, higher levels of sedentary behavior are associated with elevated fasting 
blood glucose compared to those who are less sedentary. Moreover, compared to those 
who engage in higher amounts of daily steps, those taking less daily steps, have worse 
HDL-C levels (the good cholesterol). Multivariate analyses suggest that once daily 
steps are taken into account, the relationship between sedentary behavior and worse 
fasting glucose is ameliorated. In addition, lower daily steps is independent from 
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multiple confounders (including sedentary behavior), associated with lower HDL-C. 
Previous research, in the general population has established that a one hour 
increase in sedentary behavior is associated with a 22% and 39% increased risk of 
diabetes and metabolic syndrome respectively [14, 30]. The literature suggesting the 
deleterious impact of sedentary behavior among people with schizophrenia is 
relatively sparse, although clearly there are concerns given the recently reported high 
levels [16]. Previous Stubbs et al [17] demonstrated among 250 people with 
established psychosis of similar age to the current study that higher levels of 
sedentary behavior were independently associated with increased C reactive protein 
[17]. In another study Vancampfort et al [18] found that patients (total n=76) who 
reported sitting more than 10.4 hours per day had a higher BMI, waist circumference 
and fasting glucose concentrations and experienced more negative and cognitive 
symptoms than those sitting less than 5.8 hours per day. Our study extends the 
literature, since it is the first study using objective sedentary behavior to explore the 
potential independent relationship with cardiometabolic outcomes. In particular, our 
data suggests that higher levels of sedentary behavior are associated with higher 
fasting blood glucose. 
Interestingly, the relationship between sedentary behavior and fasting blood 
glucose was attenuated once objectively measured daily steps were adjusted for in the 
model.  Moreover, it appears that higher daily steps are independently associated 
with more favorable HDL-C levels. These are relationships that have not previously 
been reported in the literature using accelerometers and help to shed some light on the 
respective metabolic risk associated with activity and sedentary behavior. In the 
general population, there is a robust relationship between the number of steps and 
cardiometabolic risk [31, 32]. Consequently, recommendations exist that people strive 
to achieve 10,000 steps per day, or at least 7,500 in some special populations [31].  
Within our study, whilst the control group met the recommended guidelines, those 
with schizophrenia engaged in just over 6,000 steps. Our data suggest that increasing 
daily steps might be an important strategy to mitigate metabolic risk in people with 
established psychosis. Moreover, walking is known to be a favored strategy for 
physical activity among people with schizophrenia and confers good health benefits 
[33, 34]. Therefore, the combined message of ‘sitting less and walking more’ might 
offer health benefits for people with psychosis [35]. Clearly, future longitudinal and 
interventional work are required to test these hypotheses and see if increasing activity 
levels and reducing sedentary behavior improves cardiometabolic profile and other 
health outcomes. 
Some limitations should be noted. First, our data are cross sectional and 
directionality of the variables cannot be clarified. Second, the participants were all 
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inpatients with established psychosis and the results may not be generalizable. Future 
research should consider these relationships in outpatients. Moreover, future research 
should consider younger populations during earlier onset of illness and before 
metabolic risk increases. For instance, targeting people experiencing first episode 
psychosis to reduced sedentary behaviors and increase activity levels may be a 
particularly key time to prevent the onset of metabolic disease. Nonetheless, the 
current study is the largest to consider objective sedentary behavior and daily steps 
and metabolic outcomes among inpatients  with schizophrenia. 
In conclusion, our study confirms that inpatients with established 
schizophrenia are highly sedentary and engage in considerably less daily steps than 
the recommended amount. Our study also suggests that whilst higher levels of 
sedentary behavior are associated with higher fasting glucose, this relationship may be 
attenuated by factoring in daily steps. Moreover, higher daily steps are independently 
associated with a more favorable HDL-C level. Future interventional work is required 
to consider if interventions focusing on ‘sitting less and walking more’ can improve 
metabolic outcomes in people with schizophrenia. 
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Figure 1: Sedentary time, steps, and metabolic parameters between patients with schizophrenia and controls 
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 p<.001;     p<.001;      p<.001;    p=.303;     p=.053;      p=.010;    p=.001;    p=.012 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
Table 1: Characteristic of patients with schizophrenia and controls 
Variables 
% or Mean(SD) 
n Patients n Controls p 
Age (years) 199 44.0(9.9) 60 41.1(9.6) .052 
BMI (kg/m
2
) 199 24.3(4.3) 60 23.9(3.7) .520 
Education (years) 199 11.4(2.2) 60 14.9(3.5) <.001 
Sex (%)      
Female 77 38.7 26 43.3 .520 
Male 122 61.3 34 56.7  
Smoke (%)     .001 
Never 114 57.3 49 81.7  
Yes 85 42.7 11 18.3  
Alcohol (%)     .771 
Never 166 83.4 51 85.0  
Yes 33 16.6 9 15.0  
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Table 2: Key variables in patients with schizophrenia by levels of sedentary and steps 
Variables / Mean(SD) Sedentary time (cut-off: 581.1 min/day) Steps (cut-off: 6628.1 steps) 
Low (n=110) High (n=89) p Low (n=93) High (n=106) p 
Sedentary (min/day) 493.3(73.2) 689.6(91.8) <.001 623.6(142.8) 543.8(99.1) <.001 
Steps (unit: 1 step) 7614.9(3578.0) 5408.5(2618.3) <.001 3648.8(1809.7) 9242.0(1920.3) <.001 
Waist (cm) 87.6(11.6) 85.8(10.6) .253 86.4(12.2) 87.1(10.2) .703 
SBP (mmHg) 112.9(12.6) 112.2(13.9) .725 111.1(14.1) 113.9(12.2) .132 
DBP (mmHg) 71.0(9.2) 71.5(8.3) .690 70.6(9.2) 71.7(8.4) .391 
TG (mg/dl) 135.7(75.2) 131.0(67.5) .643 133.6(66.6) 133.7(76.3) .991 
HDL-C (mg/dl) 46.7(13.5) 47.3(13.2) .768 44.6(11.7) 49.0(14.3) .018 
FBG (mg/dl) 96.3(19.1) 105.2(37.1) .042 102.4(33.6) 98.3(23.9) .334 
PANSS 61.4(20.1) 64.9(20.0) .209 65.7(20.6) 60.6(19.2) .071 
Chlorpromazine equivalent 
doses 
859.4(856.0) 833.1(688.6) .815 912.0(864.4) 791.2(715.4) .279 
Lorazepam equivalent 
doses 
1.1(1.4) 1.1(1.1) .886 1.0(1.1) 1.2(1.4) .402 
Time since illness onset 
(year) 
23.2(7.1) 24.5(5.8) .193 24.2(6.0) 23.4(7.0) .429 
Duration of hospitalization 
(month) 
16.1(19.5) 11.5(13.1) .047 10.3(6.7) 17.3(22.0) .002 
Key: Waist: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglycerides, HDL-C: high-density 
lipoprotein, FBG: fasting blood glucose, PANSS: Positive and negative syndrome scale 
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Table 3: Multivariable linear regressions of metabolic parameters in patients with schizophrenia (without adjusting steps) 
Variables 
Waist 
(R
2
= 13.4) 
SBP
 
(R
2
= 5.8) 
DBP 
(R
2
= 1.1) 
TG 
(R
2
= 5.5) 
HDL-C 
(R
2
= 8.0) 
FBG 
(R
2
= 15.6) 
Beta p Beta p Beta p Beta p Beta p Beta p 
Age
 
(>40) a -.131 .070 .001 .984 -.042 .581 .047 .533 .182 .015 .147 .039 
Sex
 
(Male)
 a
 .284 .001 .243 .008 .046 .622 .206 .024 -.122 .173 -.287 .001 
Education -.015 .840 .010 .896 .015 .847 .017 .820 -.032 .664 -.074 .300 
Smoke
 
(Yes)
 a
 .161 .060 -.069 .442 .011 .905 -.038 .671 -.123 .165 -.052 .536 
Alcohol
 
(Yes)
 a
 -.012 .875 .061 .439 .002 .980 .022 .782 -.026 .738 -.031 .677 
PANSS .174 .030 -.118 .159 .008 .929 -.162 .053 -.020 .809 .014 .862 
Chlorpromazine 
equivalent doses 
-.054 .455 -.112 .141 -.059 .451 .021 .779 -.004 .957 -.031 .672 
Lorazepam equivalent 
doses 
.018 .804 .028 .711 .050 .520 -.076 .315 .061 .417 -.005 .947 
Time since illness onset 
(year) 
-.015 .832 -.043 .567 .039 .611 .055 .464 -.072 .332 -.108 .130 
Duration of 
hospitalization (month) 
.074 .308 -.022 .769 .043 .579 .047 .538 -.033 .660 .097 .176 
Steps
 
(Low)
 a
             
Sedentary time (High)
 a
 -.004 .959 -.019 .801 .036 .642 -.022 .773 -.016 .826 .146 .041 
Key: 
a
: dummy variable, Waist: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglycerides, HDL-C: 
high-density lipoprotein, FBG: fasting blood glucose, PANSS: Positive and negative syndrome scale 
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Table 4: Multivariable linear regressions of metabolic parameters in patients with schizophrenia (adjusting steps) 
Variables 
Waist 
(R
2
= 13.8) 
SBP
 
(R
2
= 6.3) 
DBP 
(R
2
= 1.4) 
TG 
(R
2
= 5.7) 
HDL-C 
(R
2
= 12.1) 
FBG 
(R
2
= 15.6) 
Beta p Beta p Beta p Beta p Beta p Beta p 
Age
 
(>40) a -.133 .064 .004 .954 -.040 .604 .045 .551 .190 .009 .147 .040 
Sex
 
(Male)
 a
 .296 .001 .229 .013 .034 .718 .215 .020 -.163 .068 -.284 .001 
Education -.012 .866 .007 .922 .013 .870 .019 .803 -.040 .585 -.073 .305 
Smoke
 
(Yes)
 a
 .160 .062 -.067 .451 .012 .895 -.039 .664 -.119 .170 -.053 .535 
Alcohol
 
(Yes)
 a
 -.011 .888 .059 .450 .001 .992 .023 .773 -.030 .692 -.031 .681 
PANSS .187 .022 -.104 .218 .019 .823 -.172 .044 .020 .804 .011 .895 
Chlorpromazine 
equivalent doses 
-.064 .385 -.102 .184 -.050 .528 .014 .851 .027 .720 -.033 .651 
Lorazepam equivalent 
doses 
.028 .705 .018 .816 .041 .603 -.069 .368 .030 .688 -.002 .975 
Time since illness onset 
(year) 
-.019 .795 -.039 .601 .042 .583 .053 .486 -.061 .403 -.109 .128 
Duration of 
hospitalization (month) 
.089 .233 -.038 .625 .029 .714 .057 .460 -.080 .286 .101 .171 
Steps
 
(Low)
 a
 .071 .352 -.075 .344 -.067 .412 .051 .519 -.226 .004 .018 .810 
Sedentary time (High)
 a
 -.024 .754 .002 .978 .054 .498 -.036 .646 .047 .535 .141 .059 
Key: 
a
: dummy variable, Waist: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglycerides, HDL-C: 
high-density lipoprotein, FBG: fasting blood glucose, PANSS: Positive and negative syndrome scale 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
18 
Highlights 
 
 Sedentary behavior is related to worse fasting glucose, while this relationship is 
attenuated when physical activity is taken into account among inpatients with 
schizophrenia. 
 Physical activity is associated with favourable high-density lipoprotein cholesterol among 
inpatients with schizophrenia. 
 Interventions targeting replacing sedentary behavior with physical activity may improve 
metabolic risk among inpatients with schizophrenia. 
